Maintaining consistent quality and clinical performance of biopharmaceuticals-Reference-Cited by-同舟云学术

Maintaining consistent quality and clinical performance of biopharmaceuticals

Published:2018-01-10 Issue:4 Volume:18 Page:369-379
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Lamanna William C.¹,Holzmann Johann²,Cohen Hillel P.³,Guo Xinghua²,Schweigler Monika²,Stangler Thomas²,Seidl Andreas⁴,Schiestl Martin¹

Affiliation:

1. Sandoz Biopharmaceuticals, Sandoz GmbH, Kundl, Austria

2. Technical Development Biosimilars, Biologics Technical Development and Manufacturing, Novartis, Sandoz GmbH, Kundl, Austria

3. Scientific Affairs, Sandoz Inc, Princeton, NJ, USA

4. Technical Development Biosimilars, Biologics Technical Development and Manufacturing, Novartis, Hexal AG, Oberhaching, Germany

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1421169

Reference83 articles.

1. Biopharmaceutical benchmarks

2. Protein therapeutics: a summary and pharmacological classification

3. Biopharmaceutical benchmarks 2014

4. U.S. Department of Health and Human Services, Food and Drug Administration. Center for Drug Evaluation and Research List of Licensed Biological Products. 2017. cited 2017 Jul 25 Available from: https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/UCM560162.pdf

5. European Medicines Agency. European public assessment reports for human medicines. 2017. cited 2017 Jul 25 Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=WC0b01ac058001d124&searchTab=&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&startLetter=View+all&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=generics

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of World Health Organization international reference standards in the product life cycle of biosimilars;Annals of the New York Academy of Sciences;2024-09-10

3. Application of Multivariate Data Analysis on Historical Recombinant Adenovirus Zoster Vaccine Production Data for Upstream Process Improvements;Journal of Pharmaceutical Sciences;2024-05

4. International standards for monoclonal antibodies for assessing the biological activity of medicines: A status update;Biological Products. Prevention, Diagnosis, Treatment;2023-12-17

5. Combined analytical assays for the characterization of drugs binding to human IgE: Applicability to omalizumab-bearing biosimilar candidates assessment;Biomedicine & Pharmacotherapy;2023-12